Byrne Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $183K | Buy |
|
|||||
|
2025
Q3 | – | Hold |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $264K | Sell |
|
|||||
|
2024
Q4 | $358K | Sell |
|
|||||
|
2024
Q3 | $519K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $621K | Buy |
|
|||||
|
2023
Q4 | $499K | Sell |
|
|||||
|
2023
Q3 | $445K | Hold |
|
|||||
|
2023
Q2 | $396K | Sell |
|
|||||
|
2023
Q1 | $404K | Buy |
|
|||||
|
2022
Q4 | $341K | Sell |
|
|||||
|
2022
Q3 | $284K | Hold |
|
|||||
|
2022
Q2 | $318K | Sell |
|
|||||
|
2022
Q1 | $328K | Hold |
|
|||||
|
2021
Q4 | $330K | Buy |
|